Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Polaryx Therapeutics, Inc. - Common Stock
(NQ:
PLYX
)
2.530
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
936
Open
2.530
Bid (Size)
2.540 (400)
Ask (Size)
2.750 (1,800)
Prev. Close
2.530
Today's Range
2.530 - 2.530
52wk Range
2.070 - 48.91
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Polaryx Therapeutics Stock Is Surging On Thursday?
↗
May 28, 2026
Polaryx Therapeutics (NASDAQ: PLYX) stock climbs on Thursday following a $10M private placement to launch its Phase 2 SOTERIA trial for rare lysosomal storage disorders.
Via
Benzinga
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-92.8%
-92.8%
1 Month
-44.3%
-44.3%
3 Month
-3.4%
-3.4%
6 Month
-92.8%
-92.8%
1 Year
-92.8%
-92.8%
More News
Read More
Tuesday's session: top gainers and losers
↗
May 26, 2026
Via
Chartmill
Top stock movements in today's session.
↗
May 26, 2026
Via
Chartmill
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
May 14, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
April 23, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
April 21, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
April 15, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
April 01, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
March 17, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events
March 12, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?
↗
March 11, 2026
Via
Stocktwits
Topics
ETFs
Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders
February 27, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Polaryx Therapeutics Stock Wednesday?
↗
February 18, 2026
Via
Benzinga
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans
↗
February 17, 2026
Via
Benzinga
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
February 17, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 05, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 03, 2026
From
Polaryx Therapeutics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Polaryx Therapeutics, Inc. - Common Stock publicly traded?
Yes, Polaryx Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Polaryx Therapeutics, Inc. - Common Stock trade on?
Polaryx Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Polaryx Therapeutics, Inc. - Common Stock?
The ticker symbol for Polaryx Therapeutics, Inc. - Common Stock is PLYX on the Nasdaq Stock Market
What is the current price of Polaryx Therapeutics, Inc. - Common Stock?
The current price of Polaryx Therapeutics, Inc. - Common Stock is 2.530
When was Polaryx Therapeutics, Inc. - Common Stock last traded?
The last trade of Polaryx Therapeutics, Inc. - Common Stock was at 06/04/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
